secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRISPR Therapeutics AG (CRSP)
CIK:        0001674416
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0000950170-23-071505
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CRISPR Therapeutics CMO Phuong Khanh Morrow resigns effective Jan 26, 2024
--------------------------------------------------------------------------

- Dr. Morrow stepped down as Chief Medical Officer on Dec 14, 2023, effective Jan 26, 2024.
- Resignation is not due to any disagreement with the company.
- No successor or interim CMO has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674416/000095017023071505/0000950170-23-071505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674416/000095017023071505/crsp-20231214.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-071505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer